Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical. efflux transporters in Caco-2 cell monolayers

被引:158
作者
Collnot, EM
Baldes, C
Wempe, MF
Hyatt, J
Navarro, L
Edgar, KJ
Schaefer, UF
Lehr, CM [1 ]
机构
[1] Univ Saarland, Dept Biopharmaceut & Pharmaceut Technol, D-66123 Saarbrucken, Germany
[2] Eastman Chem Co, Kingsport, TN 37662 USA
关键词
P-glycoprotein; vitamin E TPGS; absorption enhancer; poly(ethylene glycol); Caco-2;
D O I
10.1016/j.jconrel.2005.11.005
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
(D)-alpha-tocopheryl poly(ethylene glycol) 1000 succinate (TPGS 1000) is a widely used form of vitamin E. TPGS 1000 is comprised of a hydrophilic polar (water-soluble) head and a lipophilic (water-insoluble) alkyl tail. TPGS 1000 has been used as a solubilizer, an emulsifier and as a vehicle for lipid-based drug delivery formulations. Most recently, TPGS 1000 has been recognized as an effective oral absorption enhancer. An enhancing effect is consistent with a surfactant-induced inhibition of P-glycoprotein (P-gp), and perhaps other drug transporter proteins; however, the exact inhibition mechanism(s) remain unclear. Therefore, in an attempt to generate additional knowledge, we have synthesized and tested various TPGS analogs containing different PEG chain length (TPGS 200/238/400/600/1000/2000/3400/3500/4000/6000). These results demonstrate a relationship between TPGS PEG chain length and influence on rhodamine 123 (RHO) transport in Caco-2 monolayers, a relationship which may be illustrated using a Weibull distribution. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 41 条
[21]   Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines [J].
Lo, YI .
JOURNAL OF CONTROLLED RELEASE, 2003, 90 (01) :37-48
[22]   Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats [J].
Lo, YL .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (09) :1381-1390
[23]   Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients [J].
Malingré, MM ;
Beijnen, JH ;
Rosing, H ;
Koopman, FJ ;
Jewell, RC ;
Paul, EM ;
Huinink, WWT ;
Schellens, JHM .
BRITISH JOURNAL OF CANCER, 2001, 84 (01) :42-47
[24]  
Mistry P, 2001, CANCER RES, V61, P749
[25]   Impact of drug transporter studies on drug discovery and development [J].
Mizuno, N ;
Niwa, T ;
Yotsumoto, Y ;
Sugiyama, Y .
PHARMACOLOGICAL REVIEWS, 2003, 55 (03) :425-461
[26]   Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the Oocytes of Xenopus laevis [J].
Nakanishi, T ;
Doyle, LA ;
Hassel, B ;
Wei, YT ;
Bauer, KS ;
Wu, SL ;
Pumplin, DW ;
Fang, HB ;
Ross, DD .
MOLECULAR PHARMACOLOGY, 2003, 64 (06) :1452-1462
[27]   Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers [J].
Rege, BD ;
Kao, JPY ;
Polli, JE .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 16 (4-5) :237-246
[28]   Reversal of multidrug resistance and increase in plasma membrane fluidity in CHO cells with R-verapamil and bile salts [J].
Schuldes, H ;
Dolderer, JH ;
Zimmer, G ;
Knobloch, J ;
Bickeböller, R ;
Jonas, D ;
Woodcock, BG .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (05) :660-667
[29]   The effects of Pluronic® block copolymers and Cremophor® EL on intestinal lipoprotein processing and the potential link with P-glycoprotein in Caco-2 cells [J].
Seeballuck, F ;
Ashford, MB ;
O'Driscoll, CM .
PHARMACEUTICAL RESEARCH, 2003, 20 (07) :1085-1092
[30]   Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes [J].
Shono, Y ;
Nishihara, H ;
Matsuda, Y ;
Furukawa, S ;
Okada, N ;
Fujita, T ;
Yamamoto, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (04) :877-885